FDA Investigation Finds No Safety Problems With Medtronic’s Concerto
This article was originally published in The Gray Sheet
Executive Summary
FDA said it found nothing to warrant concern following a "thorough" investigation of allegations by a former Medtronic employee about the safety of the firm's Concerto cardiac resynchronization/ defibrillator device